Valuation — not yet established
No valuation for Reprise Biomedical is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($47.1M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 6 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Reprise Biomedical
Create free account
No card required
Funding history
6 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| May 2026 | Seed Round | $1.4M | ▮ | ▮ |
| Jun 2025 | Early Stage VC | $6.4M | ▮ | ▮ |
| Oct 2023 | Early Stage VC | $8.0M | ▮ | ▮ |
| Dec 2022 | Early Stage VC | $15.3M | ▮ | ▮ |
| Nov 2020 | Seed Round | $5.0M | ▮ | ▮ |
| Jun 2019 | Early Stage VC | $12.5M | ▮ | ▮ |
How Reprise Biomedical's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Reprise Biomedical, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Reprise Biomedical raised?
- Reprise Biomedical has raised $47.1M in total funding across 6 recorded rounds.
- When did Reprise Biomedical last raise?
- Reprise Biomedical last raised in May 2026 (Seed Round), raising $1.4M.